Trials / Unknown
UnknownNCT03282435
Treatment of Non-small Cell Lung Cancer With Cytokine-induced Killer (CIK) Cells Blocked by PD-1 Antibody
Treatment of Non-small Cell Lung Cancer With CIK Cells Blocked by PD-1 Antibody
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Dalian University · Academic / Other
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
to evaluate the prognosis of non-small cell lung carcinoma patients under CIK cellular treatment with PD-1 blocking on top of the standard therapy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | CIK cells with PD-1 blocking | CIK cellular therapy with PD-1 blocking |
| OTHER | standard lung cancer treament | standard non-small cell lung cancer treatment: surgery, chemotherapy |
| BIOLOGICAL | CIK cells without PD-1 blocking | CIK cellular therapy without PD-1 blocking |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2023-01-01
- Completion
- 2023-01-01
- First posted
- 2017-09-14
- Last updated
- 2017-09-14
Source: ClinicalTrials.gov record NCT03282435. Inclusion in this directory is not an endorsement.